Dolon is a leading, strategic consultancy specialising in pricing and market access for rare disease medicines. 

We partner and provide strategic guidance to global and national pharmaceutical companies on a variety of market access and policy issues globally. Our goal is to ensure that effective rare disease treatments are made accessible to the patients who need them, in a way that is sustainable for both the pharmaceutical industry and society.

Our market access specialists deliver solutions at a therapy, disease, portfolio and industry level to realise success throughout the product life cycle. We provide services in the following areas:

•	Value, Price and Access
•	Market Access Policy
•	Data and Analytics

Headquartered in London, and with offices globally, we are a team of enthusiastic and intellectually curious individuals who share a passion for collaboration and solving complex problems. 


Consulting

Health Care

Life Sciences

Pharmaceutical

Dolon Ltd

Adam Hutchings

Carina Bloxham

Emily Lewis

Madeleine Sammons

Anna Albiero

Mansi Vithlani

Melissa Whelan - McIpd

Richard Dutton

Dolon Ltd

Org chart

Teams

Offices

Similar companies